Pharmaceutical Barium sulfate
Jack-in-the-Stox: Ucore and the Rare Earth Separation Bottleneck
In this ongoing “Jack-in-the-Stox” Q&A series, Jack Lifton examines the companies, technologies, and geopolitical realities shaping the global critical minerals…
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Advances Mine-to-Bottle Strategy for Critical Mineral Barium and Iodine Contrast Products
June 26, 2025 — Prices for pharmaceutical-grade barium sulfate “are up over 40-50% in just a few months,”…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Wednesday, June 25, 2025 at 9 AM EST
InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, June 25th, at 9 AM EST, featuring Brent Willis, President, CEO,…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, February 6, 2025
Investor.News is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, February 6th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ Shift to Innovative Barium Contrast Formulations and an FDA Update
September 17, 2024 — In a recent interview with InvestorNews host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Brent Willis on Voyageur’s ambition to revolutionize radiology by vertically integrating the barium and iodine contrast market
June 3, 2024 — InvestorNews host Pat Bolland interviews Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Voyageur Pharmaceutical’s Brent Willis on Revolutionizing the Medical Imaging Industry, plus SmoothX
In a revealing interview on Investor.Coffee, host Tracy Weslosky engages in an enlightening conversation with Brent Willis, President,…
No CommentsInvestorNews
-
Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
3 CommentsInvestorNews
InvestorNews Member News
-
Trinity One Metals Provides Project and Corporate Update
-
Discovery of Niobium-Rare Earth Carbonatite System Identified at Overland Project
-
Stakeholder Launches Next Phase of Growth at Ballarat: Class 3 Permit Application Filed to Unlock Expanded Drilling in the Heart of Yukon’s White Gold District
-
Ucore Produces 99.9% Dysprosium Oxide Sample Material for Japanese, South Korean, and US Customer Qualifications
-
Western Uranium & Vanadium Reports a Greater Than 40% Grade Increase In The Final Assays of Uranium Deliveries
